FYTVIVO Trademark

Trademark Overview


On Wednesday, December 17, 2025, a trademark application was filed for FYTVIVO with the United States Patent and Trademark Office. The USPTO has given the FYTVIVO trademark a serial number of 99552330. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 28, 2026. This trademark is owned by Juno Therapeutics, Inc.. The FYTVIVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
fytvivo

General Information


Serial Number99552330
Word MarkFYTVIVO
Filing DateWednesday, December 17, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 28, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2026

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJuno Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
US

Trademark Events


Event DateEvent Description
Wednesday, December 17, 2025NEW APPLICATION ENTERED
Wednesday, December 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 17, 2025APPLICATION FILING RECEIPT MAILED
Monday, April 20, 2026ASSIGNED TO EXAMINER
Tuesday, April 21, 2026APPROVED FOR PUB - PRINCIPAL REGISTER